In patients who lack an MEN1 pathogenic variant but have clinical symptoms similar to MEN1 syndrome, germline mutations in CDKN1B should be examined by next-generation sequencing (NGS). Here, MEN1 is linked to multiple endocrine neoplasia type 1.